Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients অনুযায়ী Cloud P. Paweletz (14960112)

বিষয়গুলি:

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... অনুযায়ী Stephanie Lheureux (16797697)

বিষয়গুলি:

Supplementary Table S5 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... অনুযায়ী Stephanie Lheureux (16797697)

বিষয়গুলি:

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... অনুযায়ী Stephanie Lheureux (16797697)

বিষয়গুলি:

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... অনুযায়ী Stephanie Lheureux (16797697)

বিষয়গুলি:

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... অনুযায়ী Stephanie Lheureux (16797697)

বিষয়গুলি:

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation অনুযায়ী Francesca Orzan (15055579)

বিষয়গুলি:

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation অনুযায়ী Francesca Orzan (15055579)

বিষয়গুলি:

Integrating urinary metabolomics and clinical datasets for multi-cancer detection অনুযায়ী Dongyong Lee (18786694)

বিষয়গুলি:

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation অনুযায়ী Francesca Orzan (15055579)

বিষয়গুলি:

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... অনুযায়ী Kala Visvanathan (14952973)

বিষয়গুলি:

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... অনুযায়ী Kala Visvanathan (14952973)

বিষয়গুলি:

Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... অনুযায়ী Kala Visvanathan (14952973)

বিষয়গুলি:

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... অনুযায়ী Kala Visvanathan (14952973)

বিষয়গুলি:

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... অনুযায়ী Kala Visvanathan (14952973)

বিষয়গুলি:

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer অনুযায়ী Martin Sjöström (14845882)

বিষয়গুলি:

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer অনুযায়ী Martin Sjöström (14845882)

বিষয়গুলি:

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer অনুযায়ী Martin Sjöström (14845882)

বিষয়গুলি:

Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer অনুযায়ী Whitney L. Hensing (16461978)

বিষয়গুলি:

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer অনুযায়ী Martin Sjöström (14845882)

বিষয়গুলি: